NEXUS GLOBAL GROUP
Live / Allowed — Publication / registration review complete (as of 09 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Feb 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99638532
- Mark type
- Stylized text
- Filed
- 06 Feb 2026
- Published for opposition
- 29 Sept 2026
- Attorney of record
- Matthew J. Gryzlo
Goods and services
- Class 035 — Advertising and business services: New product commercialization services; Competitive intelligence services; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Business consultation and management regarding marketing activities and launching of new products; Brand positioning services; Business strategy development services; Marketing and branding services, namely, providing customized communication programs to obtain consumer insights and develop branding strategies; Marketing services; Marketing consulting; Marketing advisory services; Digital marketing services; Providing advertising, marketing and promotional services for the pharmaceutical and medical products of others; Consultancy regarding advertising communication strategies; Creative marketing plan development services; Creating and updating advertising material; Public relations; Public relations consultancy; Media relations services; Consulting in sales techniques and sales programs; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; Consulting services in the field of medical product approval for commercial purposes; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of pharmaceutical development; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; Organizing business networking events in the field of pharmaceuticals; Organizing exhibitions for commercial or advertising purposes
- Class 041 — Education and entertainment services: Arranging, conducting, and organization of seminars, lecture presentations and symposiums in the field of healthcare and pharmaceuticals for use by others in their internal training; Arranging and conducting of lectures in the field of healthcare and pharmaceuticals; Providing classes, seminars, workshops, presentations and retreats in the field of health; Consultancy relating to arranging and conducting of congresses; Consultancy relating to arranging and conducting of conferences; Arranging and conducting of conferences and symposia in the field of medical science; Business training; Arranging and conducting of training seminars in the field of pharmaceutical research; Writing of articles for professional journals other than for advertising or publicity
- Class 042 — Scientific and technological services: Scientific research consulting; Technical consulting in the field of pharmaceutical studies; Research and development in the pharmaceutical and biotechnology fields; Consulting services in the field of pharmaceutical research and development; Providing medical research information in the field of pharmaceuticals; Consulting services for others in the field of design, planning, and implementation project management of clinical trials
- Class 045 — Legal and security services: Providing information about legal eligibility requirements for government medical and pharmaceutical programs; Regulatory compliance consultancy in the field of pharmaceuticals
Owner
- Vaniam Group LLC, Chicago, IL, US
Prosecution history
- 03 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Jun 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Jun 2026 — NON-FINAL ACTION E-MAILED
- 04 Jun 2026 — NON-FINAL ACTION WRITTEN
- 03 Jun 2026 — ASSIGNED TO EXAMINER
- 06 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 06 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Feb 2026 — NEW APPLICATION ENTERED